Brought to you by:
Brian McHugh
Analysis will kickstart conversation on F/BEVAR outcomes
New data presented during Friday’s Plenary Session 6 (10–11 a.m. in the West Building, Skyline Ballroom) will shed light on trends in the adoption of fenestrated and branched endovascular aortic repair (F/BEVAR) outside of Food and Drug Administration (FDA) Investigational…
SVS, AVF bring the latest innovations in venous disease treatment to VAM
During the first day of VAM 2024, the Society for Vascular Surgery (SVS) and American Venous Forum (AVF) have co-sponsored a session on the latest innovations in the delivery of venous disease treatment. Madhavi Meka, MD, a clinical associate professor…